Key points are not available for this paper at this time.
IL-12 is a central cytokine in the activation of inflammation and immunity and in the generation of Th1-type responses. Tumor-associated macrophages (TAM) from mouse and human tumors showed defective production of IL-12. Defective IL-12 production was associated with lack of p50/p65 NF-kappa B activation. TAM produced increased amounts of the immunosuppressive cytokine IL-10. Abs against IL-10 restored the defective capacity of TAM to produce IL-12. Our data suggest that during tumor growth an IL-10-dependent pathway of diversion of macrophage function can be activated into the tumor microenvironment and results in the promotion of the IL-10+ IL-12- phenotype of TAM. Blocking IL-10, as well as other immunosuppressive cytokines present in the tumor microenvironment, such as TGF-beta, may complement therapeutic strategies aimed at activating type I antitumor immune responses.
Building similarity graph...
Analyzing shared references across papers
Loading...
Antonio Sica
Alessandra Saccani
Barbara Bottazzi
The Journal of Immunology
KU Leuven
Mario Negri Institute for Pharmacological Research
University of Brescia
Building similarity graph...
Analyzing shared references across papers
Loading...
Sica et al. (Sat,) studied this question.
www.synapsesocial.com/papers/6a04dd097664c2ac4b2a233c — DOI: https://doi.org/10.4049/jimmunol.164.2.762
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: